Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2. - Pusceddu, Sara; Corti, Francesca; Prinzi, Natalie; Nichetti, Federico; Ljevar, Silva; Busico, Adele; Cascella, Tommaso; Leporati, Rita; Oldani, Simone; Pircher, Chiara Carlotta; Coppa, Jorgelina; Resi, Veronica; et al. (Journal of Hematology & Oncology, 2023)